Click for next page ( 134


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 133
REFERENCES AIDSTAR-One. 2009. Integrating multiple gender strategies to improve HIV and AIDS interventions: A compendium of programs in Africa. Washington, DC: International Center for Research on Women. Alagiri, P., C. Collins, T. Summers, S. Morin, and T. Coates. 2001. Global spending on HIV/AIDS: Tracking public and private investments in AIDS prevention, care, and research. Washington, DC: Kaiser Family Foundation. Atun, R., and N. Menabde. 2008. Health systems and systems thinking. In Health systems and the challenge of communicable disease, edited by R. Coker, R. Atun and M. McKee. Berkshire, United Kingdom: Open University Press. Auvert, B., D. Taljaard, E. Lagarde, J. Sobngwi-Tambekou, R. Sitta, and A. Puren. 2005. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 trial. PLoS Med 2(11):e298. Bailey, R. C., S. Moses, C. B. Parker, K. Agot, I. Maclean, J. N. Krieger, C. F. Williams, R. T. Campbell, and J. O. Ndinya-Achola. 2007. Male circumcision for HIV prevention in young men in Kisumu, Kenya: A randomised controlled trial. Lancet 369(9562):643–656. Bendavid, E., and J. Bhattacharya. 2009. The President’s Emergency Plan for AIDS Relief in Africa: An evaluation of outcomes. Ann Int Med 150:688–695. Bertozzi, S. M. 2006. Modeling the impact of antiretroviral use in developing countries. PLoS Med 3(4):e148. Bertozzi, S., T. E. Martz, and P. Piot. 2009. The evolving HIV/AIDS response and the urgent tasks ahead Health Aff 28(6):1585. Bongaarts, J., T. Buettner, G. Heilig, and F. Pelletier. 2008. Has the HIV epidemic peaked? Popul Dev Rev 34(2):199–224. Bouey, P. 2010. PEPFAR next generation strategic information. Presentation, Public information- gathering session of the Committee on Planning the Assessment/Evaluation of HIV/AIDS Programs Implemented Under the U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008, Washington, DC, January 7. Bressler, S. 2009. Presentation, First Committee Meeting on Planning the Assessment/Evaluation of HIV/AIDS Programs Implemented Under the U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008, Washington, DC, November 23. Bush, G. W. 2003. 2003 State of the Union address. http://georgewbush- whitehouse.archives.gov/news/releases/2003/01/20030128-19.html (accessed June 8, 2010). Bussmann, H., C. W. Wester, N. Ndwapi, N. Grundmann, T. Gaolathe, J. Puvimanasinghe, A. Avalos, M. Mine, K. Seipone, M. Essex, V. Degruttola, and R. G. Marlink. 2008. Five-year outcomes of initial patients treated in Botswana’s national antiretroviral treatment program. AIDS 22(17):2303–2311. CDC (U.S. Centers for Disease Control and Prevention). 1981. Pneumocystis pneumonia—Los Angeles. MMWR 30(21):1–3. CIDA (Canadian International Development Agency). Project browser. http://les.acdi-cida.gc.ca/project- browser (accessed June 23, 2010). Cluver, L., and F. Gardner. 2007. The mental health of children orphaned by AIDS: A review of international and Southern African research. Child Adolesc Ment Health 19(1):1–17. Cluver, L., and M. Orkin. 2009. Stigma, bullying, poverty and AIDS-orphanhood: Interactions mediating psychological problems for children in South Africa. Soc Sci Med. 69(8):1186–1193. Cluver, L., F. Gardner, and D. Operario. 2007. Psychological distress amongst AIDS-orphaned children in urban South Africa. J Child Psychol Psychiatry 48(8):755–763. 133

OCR for page 133
134 STRATEGIC APPROACH TO THE EVALUATION OF U.S. GLOBAL HIV/AIDS PROGRAMS Coleman, A. 2007. The U.S. President’s Emergency Plan for AIDS Relief: Global Fund technical support. Presentation, Global Fund Regional Meeting, Nusa Dua, Indonesia, September 3–5. http://www.theglobalfund.org/documents/regionalmeetings/indonesia2007/Presentation_on_ Global_Fund_Technical_Support.ppt (accessed June 14, 2010). Constella Group LLC. 2008. Software. http://constellafutures.com/fg/cdIAC/software.html (accessed April 7, 2010). Corbett, E. L., C. J. Watt, N. Walker, D. Maher, B. G. Williams, M. C. Raviglione, and C. Dye. 2003. The growing burden of tuberculosis: Global trends and interactions with the HIV epidemic. Arch Intern Med 163(9):1009–1021. Cornman, D. H., S. M. Kiene, S. Christie, W. A. Fisher, P. A. Shuper, S. Pillay, G. H. Friedland, C. M. Thomas, L. Lodge, and J. D. Fisher. 2008. Clinic-based intervention reduces unprotected sexual behavior among HIV-infected patients in Kwazulu-Natal, South Africa: Results of a pilot study. J Acquir Immune Defic Syndr 48(5):553–560. CRS (Congressional Research Service). 2003. HIV/AIDS international programs: Appropriations, FY2002–FY2004, edited by R. Copson.Washington, DC: Library of Congress. CRS . 2005. The Global Fund and PEPFAR in U.S. international AIDS policy, edited by R. W. Copson. Order Code RL33135. Washington, DC: CRS. CRS. 2007. PEPFAR: From emergency to sustainability, edited by T. Salaam-Blyther. Order Code RL34192. Washington, DC: CRS. CRS. 2008a. International HIV/AIDS, tuberculosis, and malaria: Key changes to U.S. programs and funding, edited by K. Moss. Order Code RL34569. Washington, DC: CRS. CRS. 2008b. Trends in U.S. global AIDS spending: FY2000-FY2008, edited by T. Salaam-Blyther. Order Code RL33771. Washington, DC: CRS. CRS. 2009. PEPFAR reauthorization: Key policy debates and changes to U.S. international HIV/AIDS, tuberculosis, and malaria programs and funding, edited by K. Moss. Order Code RL34569. Washington, DC: CRS. Cunningham, C. K., M. L. Chaix, C. Rekacewicz, P. Britto, C. Rouzioux, R. D. Gelber, A. Dorenbaum, J. F. Delfraissy, B. Bazin, L. Mofenson, and J. L. Sullivan. 2002. Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: A substudy of pediatric AIDS clinical trials group protocol 316. J Infect Dis 186(2):181–188. DAC (Development Assistance Committee) Network on Development Evaluation. 2002. Glossary of key terms in evaluation and results based management, evaluation and aid effectiveness. Paris: Organisation for Economic Co-operation and Development. DART Trial Team. 2009. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): A randomised non-inferiority trial. Lancet 375(9709):123–131. De Lay, P. 2010. Implementation strategy roundtable: The future of PEPFAR. Presentation, 17th Conference on Retroviruses and Opportunistic Infections (CROI), San Francisco, CA, February 16–19. de Savigny, D., and A. Taghreed. 2009. Systems thinking for health systems strengthening. Geneva, Switzerland: Alliance for Health Policy and Systems Research. Dick, B. 2009. Vulnerability and most at risk: Towards a common framework. Presentation, IYWG (Interagency Youth Working Group) Meeting on Young People Most-At-Risk for HIV/AIDS, Washington, DC, June 25. DFID (UK Department for International Development). Where we work. http://www.dfid.gov.uk/Where- we-work/ (accessed June 23, 2010). Dorenbaum, A., C. K. Cunningham, R. D. Gelber, M. Culnane, L. Mofenson, P. Britto, C. Rekacewicz, M. L. Newell, J. F. Delfraissy, B. Cunningham-Schrader, M. Mirochnick, and J. L. Sullivan. 2002. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: A randomized trial. JAMA 288(2):189–198.

OCR for page 133
135 REFERENCES DoS (U.S. Department of State). 2010a. FY2011 Congressional budget justification volume 2—Foreign operations. Washington, DC: DoS. DoS. 2010b. Implementation of the Global Health Initiative: Consultation document. Washington, DC: DoS. DoS OIG (U. S. Department of State and the Broadcasting Board of Governors Office of Inspector General). 2008. Review of the Office of the U.S. Global AIDS Coordinator. Report Number ISP-I- 08-23. Washington, DC: DoS. DoS OIG. 2009. The exercise of chief of mission authority in managing the President’s Emergency Plan for AIDS Relief overseas. Report Number ISP-I-10-01. Washington, DC: DoS. Dutta, A., and L. Fleisher. 2008. Planning for sustainable HIV/AIDS services using the HAPSAT tool. Presentation, Global Health Council Conference, Washington, DC, May 27. Dybul, M. 2009. Lessons learned from PEPFAR. J Acquir Immune Defic Syndr 52(Suppl. 1):S12–S13. Edgil, D. 2010. The President’s Emergency Plan for AIDS Relief: Public health evaluations. Presentation, Public information-gathering session of the Committee on Planning the Assessment/Evaluation of HIV/AIDS Programs Implemented Under the U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008, Washington, DC, January 7. Emery, S., J. A. Neuhaus, A. N. Phillips, A. Babiker, C. J. Cohen, J. M. Gatell, P. M. Girard, B. Grund, M. Law, M. H. Losso, A. Palfreeman, and R. Wood. 2008. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis 197(8):1133–1144. Forsythe, S., J. Stover, and L. Bollinger. 2009. The past, present and future of HIV/AIDS and resource allocation. Working Paper No. 20. Washington, DC: aids2031. Frenk, J. 2010. The global health system: Strengthening national health systems as the next step for global progress. PLoS Med 7(1):e1000089. GAO (U.S. Government Accountability Office). 2004. Global Health: U.S. AIDS Coordinator addressing some key challenges to expanding treatment, but others remain. GAO-04-784. Washington, DC: GAO. GAO. 2005. Global HIV/AIDS epidemic: Selection of antiretroviral medications provided under U.S. emergency plan is limited. GAO-05-133. Washington, DC: GAO. GAO. 2006. Global health: Spending requirement presents challenges for allocating prevention funding under the President’s Emergency Plan for AIDS Relief. GAO-06-395. Washington, DC: GAO. GAO. 2008. Global HIV/AIDS: A more country-based approach could improve allocation of PEPFAR funding. GAO-08-480. Washington, DC: GAO. GAO. 2009. President’s Emergency Plan for AIDS Relief: Partner selection and oversight follow accepted practices but would benefit from enhanced planning and accountability. GAO-09-666. Washington, DC: GAO. Garnett, G. P. 2002. An introduction to mathematical models in sexually transmitted disease epidemiology. Sex Transm Infect 78(1):7–12. GFATM (The Global Fund to Fight AIDS, Tuberculosis and Malaria). 2009. Global Fund ARV fact sheet: 1st December, 2009. Geneva, Switzerland: GFTAM. GFATM. 2010a. Grant portfolio. http://portfolio.theglobalfund.org/?lang=en (accessed June 23, 2010). GFATM. 2010b. The Global Fund 2010: Innovation and impact. Geneva, Switzerland: GAFTM. Girardi, E., G. Antonucci, P. Vanacore, M. Libanore, I. Errante, A. Matteelli, and G. Ippolito. 2000. Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS 14(13):1985–1991. Global HIV Prevention Working Group. 2010. Key facts. http://www.globalhivprevention.org/key_facts.html (accessed June 24, 2010). Gouws, E., K. A. Stanecki, R. Lyerla, and P. D. Ghys. 2008. The epidemiology of HIV infection among young people aged 15–24 years in Southern Africa. AIDS 22(Suppl. 4):S5–S16.

OCR for page 133
136 STRATEGIC APPROACH TO THE EVALUATION OF U.S. GLOBAL HIV/AIDS PROGRAMS Granich, R. M., C. F. Gilks, C. Dye, K. M. De Cock, and B. G. Williams. 2009. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. Lancet 373(9657):48–57. Granich, R., S. Crowley, M. Vitoria, Y. R. Lo, Y. Souteyrand, C. Dye, C. Gilks, T. Guerma, K. M. De Cock, and B. Williams. 2010. Highly active antiretroviral treatment for the prevention of HIV transmission. J Int AIDS Soc 13(1):1. Gray, R. H., G. Kigozi, D. Serwadda, F. Makumbi, S. Watya, F. Nalugoda, N. Kiwanuka, L. H. Moulton, M. A. Chaudhary, M. Z. Chen, N. K. Sewankambo, F. Wabwire-Mangen, M. C. Bacon, C. F. Williams, P. Opendi, S. J. Reynolds, O. Laeyendecker, T. C. Quinn, and M. J. Wawer. 2007. Male circumcision for HIV prevention in men in Rakai, Uganda: A randomised trial. Lancet 369(9562):657–666. Greene, J. C., V. J. Caracelli, and W. F. Graham. 1989. Toward a conceptual framework for mixed- method evaluation design. Educ Eval Policy An 11(3):255–274. Gupta, R. K., A. Hill, A. W. Sawyer, A. Cozzi-Lepri, V. WYL, S. Yerly, V. Dias Lima, H. F. Günthard, C. Gilks, and D. Pillay. 2009. Virological monitoring and resistance to first-line HAART in adults infected with HIV-1 treated under WHO guidelines: Systematic review and meta-analysis. Lancet Infect Dis 9:409–417. Hallett, T. B., B. Zaba, J. Todd, B. Lopman, W. Mwita, S. Biraro, S. Gregson, J. T. Boerma, and on behalf of the Alpha Network. 2008. Estimating incidence from prevalence in generalised HIV epidemics: Methods and validation. PLoS Med 5(4):e80. Hallett, T. B., P. Ghys, T. Bärnighausen, P. Yan, G. P. Garnett. 2009. Errors in “BED”-derived estimates of HIV incidence will vary by place, time and age. PLoS One 4(5):e5720. Hammer, S. 2010. ART is great. Presentation, 17th Conference on Retroviruses and Opportunistic Infections (CROI), San Francisco, CA, February 16–19. Heaton, L. M., R. Komatsu, D. Low-Beer, T. B. Fowler, and P. O. Way. 2008. Estimating the number of HIV infections averted: An approach and issues. Sex Transm Infect 84(Suppl. 1):i92–i96. Herbst, A. J., G. S. Cooke, T. Barnighausen, A. KanyKany, F. Tanser, and M. L. Newell. 2009. Adult mortality and antiretroviral treatment roll-out in rural Kwazulu-Natal, South Africa. Bull World Health Organ 87(10):754–762. High-Level Forum. 2005. Paris declaration on aid effectiveness: Ownership, harmonization, alignment, results, and mutual accountability, Paris, France, February 28–March 2. Holmes, C. 2009. Using costing and modeling to improve treatment (and other) program planning. Presentation, PEPFAR Annual Meeting with Track One Partners, Dar es Salaam, Tanzania, August 4. Hussey, M. A., and J. P. Hughes. 2007. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials 28(2):182–191. IEG World Bank (Independent Evaluation Group of The World Bank Group). 2009. Improving effectiveness and outcomes for the poor in health, nutrition, and population: An evaluation of World Bank Group support since 1997. Washington, DC: The World Bank. IOM (Institute of Medicine). 2005. Plan for a short-term evaluation of PEPFAR implementation. Washington, DC: The National Academies Press. IOM. 2006. Preventing HIV infection among injecting drug users in high risk countries: An assessment of the evidence. Washington, DC: The National Academies Press. IOM. 2007. PEPFAR implementation: Progress and promise. Washington, DC: The National Academies Press. IOM. 2008. Design considerations for evaluating the impact of PEPFAR: Workshop summary. Washington, DC: The National Academies Press. Jahn, A., S. Floyd, A. C. Crampin, F. Mwaungulu, H. Mvula, F. Munthali, N. McGrath, J. Mwafilaso, V. Mwinuka, B. Mangongo, P. E. Fine, B. Zaba, and J. R. Glynn. 2008. Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet 371(9624):1603–1611.

OCR for page 133
137 REFERENCES Jemmott, J. B. I., L. S. Jemmott, A. O’Leary, Z. Ngwane, L. D. Icard, S. L. Bellamy, S. F. Jones, G. A. Heeren, J. C. Tyler, and M. B. Makiwane. (in press). School-based randomized controlled trial of an HIV/std risk-reduction intervention for South African adolescents. Arch Pediatr Adolesc Med. Jewkes, R., M. Nduna, J. Levin, N. Jama, K. Dunkle, A. Puren, and N. Duvvury. 2008. Impact of stepping stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: Cluster randomised controlled trial. BMJ 337(337):a506. JLICA (The Joint Learning Initiative on Children and HIV/AIDS). 2009. Home truths: Facing the facts on children, AIDS, and poverty. Boston, MA: JLICA. Johansson, K. A., B. Robberstad, and O. F. Norheim. 2010. Further benefits by early start of HIV treatment in low income countries: Survival estimates of early versus deferred antiretroviral therapy. AIDS Res Ther 7(1):3. Kalichman, S. C., L. C. Simbayi, R. Vermaak, D. Cain, G. Smith, J. Mthebu, and S. Jooste. 2008. Randomized trial of a community-based alcohol-related HIV risk-reduction intervention for men and women in Cape Town South Africa. Ann Behav Med 36(3):270–279. Kates, J., E. Lief, and C. Avila. 2009. Financing the response to AIDS in low- and middle-income countries: International assistance from the G8, European Commission and other donor governments in 2008. Washington, DC: Kaiser Family Foundation and UNAIDS. Kaur, G., and A. Singh. 2010. The “see and treat” approach to cervical cancer. http://www.thelancetstudent.com/2010/02/16/the-see-and-treat-approach-to-cervical-cancer/ (accessed February 16, 2010). KFF (Kaiser Family Foundation). 2009. The global HIV/AIDS epidemic: Fact sheet. Washington, DC: KFF. Kuhn, L., G. M. Aldrovandi, M. Sinkala, C. Kankasa, K. Semrau, M. Mwiya, P. Kasonde, N. Scott, C. Vwalika, J. Walter, M. Bulterys, W. Y. Tsai, and D. M. Thea. 2008. Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med 359(2):130–141. Kuhn, L., G. M. Aldrovandi, M. Sinkala, C. Kankasa, K. Semrau, P. Kasonde, M. Mwiya, W. Y. Tsai, and D. M. Thea. 2009. Differential effects of early weaning for HIV-free survival of children born to HIV-infected mothers by severity of maternal disease. PLoS ONE 4(6):e6059. Lawn, S. D., A. D. Harries, X. Anglaret, L. Myer, and R. Wood. 2008. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22(15):1897–1908. Leeuw, F., and J. Vaessen. 2009. Impact evaluations and development NONIE guidance on impact evaluation. Washington, DC: NONIE (Network of Networks for Impact Evaluation). Levine, W. C. 2010. CDC’s role in PEPFAR strategic information and public health evaluation. Presentation, Public information-gathering session of the Committee on Planning the Assessment/Evaluation of HIV/AIDS Programs Implemented Under the U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008, Washington, DC, January 7. Lima, V. D., K. Johnston, R. S. Hogg, A. R. Levy, P. R. Harrigan, A. Anema, and J. S. Montaner. 2008. Expanded access to highly active antiretroviral therapy: A potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis 198(1):59–67. Marsh, P. 2009. Presentation, First Committee Meeting on Planning the Assessment/Evaluation of HIV/AIDS Programs Implemented Under the U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008, Washington, DC, November 23. MEASURE DHS (Demographic and Health Surveys). 2010. HIV/AIDS survey indicators database. http://www.measuredhs.com/hivdata/ (accessed April 14, 2010). MEASURE Evaluation. 2007. Monitoring and evaluation systems strengthening tool. Chapel Hill, NC: MEASURE Evaluation. MEASURE Evaluation. 2009. Child status index a tool for assessing the well-being of orphans and vulnerable children—Manual. Chapel Hill, NC: MEASURE Evaluation. Mermin, J., W. Were, J. P. Ekwaru, D. Moore, R. Downing, P. Behumbiize, J. R. Lule, A. Coutinho, J. Tappero, and R. Bunnell. 2008. Mortality in HIV-infected Ugandan adults receiving antiretroviral

OCR for page 133
138 STRATEGIC APPROACH TO THE EVALUATION OF U.S. GLOBAL HIV/AIDS PROGRAMS treatment and survival of their HIV-uninfected children: A prospective cohort study. Lancet 371(9614):752–759. Moloney-Kitts, M. 2009. Update on the U.S. response to the global AIDS pandemic. Presentation, Public information-gathering session of the Committee on Planning the Assessment/Evaluation of HIV/AIDS Programs Implemented Under the U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008, Washington, DC, November 23. Montaner, J. S., R. Hogg, E. Wood, T. Kerr, M. Tyndall, A. R. Levy, and P. R. Harrigan. 2006. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 368(9534):531–536. Murphy, G., and J. V. Parry. 2008. Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill 13(36):18966. Napierala-Mavedzenge, S., A. Doyle, and D. Ross. 2010. HIV prevention in young people in sub-Saharan Africa: A systematic review. London School of Hygiene & Tropical Medicine Health Policy Unit. London: London School of Hygiene & Tropical Medicine. Newell, M. L., H. Coovadia, M. Cortina-Borja, N. Rollins, P. Gaillard, and F. Dabis. 2004. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: A pooled analysis. Lancet 364(9441):1236–1243. Nyamukapa, C. A., S. Gregson, B. Lopman, S. Saito, H. J. Watts, R. Monasch, and M. C. Jukes. 2008. HIV-associated orphanhood and children’s psychosocial distress: Theoretical framework tested with data from Zimbabwe. Am J Public Health 98(1):133–141. OGAC (Office of the U.S. Global AIDS Coordinator). 2004. The U.S. President’s Emergency Plan for AIDS Relief: U.S. Five year global HIV/AIDS strategy. Washington, DC: OGAC. OGAC. 2006a. Bringing hope: Supplying antiretroviral drugs for HIV/AIDS treatment. The President’s Emergency Plan for AIDS Relief: Report on antiretroviral drugs for HIV/AIDS treatment. Washington, DC: OGAC. OGAC. 2006b. Guidance for United States government in-country staff and implementing partners for a preventive care package for adults*- #1. Washington, DC: OGAC. OGAC. 2006c. Guidance for United States government in-country staff and implementing partners for a preventive care package for children aged 0–14 years old born to HIV-infected mothers* - #1. Washington, DC: OGAC. OGAC. 2006d. HIV/AIDS palliative care guidance #1 for the United States government in-country staff and implementing partners. Washington, DC: OGAC. OGAC. 2006e. Orphans and other vulnerable children programming guidance for United States government in-country staff and implementing partners. Washington, DC: OGAC. OGAC. 2006f. The President’s Emergency Plan for AIDS Relief report on gender-based violence and HIV/AIDS. Washington, DC: OGAC. OGAC. 2006g. The President’s Emergency Plan for AIDS Relief: Report on food and nutrition for people living with HIV/AIDS. Washington, DC: OGAC. OGAC. 2008a. The power of partnerships: The U.S. President’s Emergency Plan for AIDS Relief. 2008 annual report to Congress. Washington, DC: OGAC. OGAC. 2008b. The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)—Fiscal Year 2008: PEPFAR operational plan. Washington, DC: OGAC. OGAC. 2009a. Celebrating life: The U.S. President’s Emergency Plan for AIDS Relief. 2009 annual report to Congress. Washington, DC: OGAC. OAGC. 2009b. Guidance for PEPFAR partnership frameworks and partnership framework implementation plans. Version 2.0. Washington, DC: OGAC. OGAC. 2009c. PEPFAR: State of the program area. Washington, DC: OGAC. OGAC. 2009d. The President’s Emergency Plan for AIDS Relief next generation indicators reference guidance. Version 1.1. Washington, DC: OGAC. OGAC. 2009e. The President’s Emergency Plan for AIDS Relief. FY2010 country operational guidance: Programmatic considerations. Washington, DC: OGAC.

OCR for page 133
139 REFERENCES OGAC. 2009f. The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)—Fiscal year 2009: PEPFAR operational plan. Washington DC: OGAC. OGAC. 2009g. The U.S. President’s Emergency Plan for AIDS Relief: Five-year strategy. Washington, DC: OGAC. OGAC. 2009h. The U.S. President’s Emergency Plan for AIDS Relief: Five-year strategy. Annex: PEPFAR’s contributions to the Global Health Initiative. Washington, DC: OGAC. OGAC. 2009i. The U.S. President’s Emergency Plan for AIDS Relief: Five-year strategy. Annex: PEPFAR and prevention, care, and treatment. Washington, DC: OGAC. OGAC. 2010. The U.S. President’s Emergency Plan for AIDS Relief: 2009 annual report to Congress on PEPFAR program results. Washington, DC: OGAC. OHCHR (Office of the High Commissioner for Human Rights). 2007. Committee on the rights of the child: Sessions. http://www2.ohchr.org/english/bodies/crc/sessions.htm (accessed May 28, 2010). PEPFAR (U.S. President’s Emergency Plan for AIDS Relief). 2007. About OGAC: Organizational chart. http://www.pepfar.gov/c22835.htm (accessed March 25, 2010). PEPFAR. 2008a. Data quality assessment tool (for auditing and capacity building). http://www.pepfar.gov/implementer_resources/data_quality/c20984.htm (accessed May 17, 2010). PEPFAR. 2008b. Premier global companies, U.S. government launch unprecedented partnership for an HIV-Free Generation. The U.S. President’s Emergency Plan for AIDS Relief announces public- private partnership for global HIV prevention for youth. HIV-Free Generation Press Release, December 5. http://www.pepfar.gov/documents/organization/112564.pdf (accessed April 16, 2010). PEPFAR. 2009a. Draft agenda. The United States President’s Emergency Plan for AIDS Relief Annual Meeting—Optimizing the Response: Partnerships for Sustainability, Windhoek, Namibia, June 8– 10. PEPFAR. 2009b. Technical support to Global Fund grants (updated September 2009). http://www.pepfar.gov/coop/boardmeetings/91395.htm (accessed June 14, 2010). PEPFAR. 2009c. Total number of individuals reached (on antiretroviral treatment FY2005–FY2008). http://www.pepfar.gov/about/tables/treatment/123461.htm (accessed March 9, 2010). PEPFAR. 2010a. Implementing agencies: Department of Commerce (DoC). http://www.pepfar.gov/agencies/c19398.htm (accessed June 15, 2010). PEPFAR. 2010b. Technical note on PEPFAR’s reporting methodology: Results of USG Global Fund contributions. http://www.pepfar.gov/2009results/ (accessed June 16, 2010). PEPFAR. 2010c. The U.S. President’s Emergency Plan for AIDS Relief: Reports. http://www.pepfar.gov/progress/index.htm (accessed April 14, 2010). PEPFAR and USAID (United States Agency for International Development). 2007. Data quality assurance tool for program-level indicators. Washington, DC: USAID. PEPFAR Reauthorization Action Team. 2010. Top 11 facts to know about PEPFAR. http://www.pepfar2.org/facts.html#top10 (accessed March 9, 2010). Phillips, A., and J. van Oosterhout. 2010. DART points the way for HIV treatment programmes. Lancet 375(9709):96–98. PMI (The President’s Malaria Initiative). 2009. Fast facts: The President’s Malaria Initiative (PMI). Washington, DC: PMI. Resch, S., H. Wang, M. Kayode Ogungbemi, and G. Kombe. 2009. Sustainability analysis of HIV/AIDS services in Nigeria. Bethesda, MD: Health Systems 20/20 Project, Abt Associates Inc. Rugg, D., G. Peersman, and M. Carael, eds. 2004. Global advances in HIV/AIDS monitoring and evaluation: New directions for evaluation. San Francisco, CA: Jossey-Bass. Samb, B., T. Evans, M. Dybul, R. Atun, J. P. Moatti, S. Nishtar, A. Wright, F. Celletti, J. Hsu, J. Y. Kim, R. Brugha, A. Russell, and C. Etienne. 2009. An assessment of interactions between global health initiatives and country health systems. Lancet 373(9681):2137–2169.

OCR for page 133
140 STRATEGIC APPROACH TO THE EVALUATION OF U.S. GLOBAL HIV/AIDS PROGRAMS Shaffer, N., M. McConnell, O. Bolu, D. Mbori-Ngacha, T. Creek, R. Ntumy, and L. Mazhani. 2004. Prevention of mother-to-child HIV transmission internationally. Emerg Infect Dis 10(11):2027– 2028. Shakarishvili, G. 2009 (unpublished). Building on health systems frameworks for developing a common approach to health systems strengthening. Paper presented at World Bank, the Global Fund and the GAVI Alliance Technical Workshop on Health Systems Strengthening, Washington, DC, June 25–27. Stanton, B. F., X. Li, J. Kahihuata, A. M. Fitzgerald, S. Neumbo, G. Kanduuombe, I. B. Ricardo, J. S. Galbraith, N. Terreri, I. Guevara, H. Shipena, J. Strijdom, R. Clemens, and R. F. Zimba. 1998. Increased protected sex and abstinence among Namibian youth following a HIV risk-reduction intervention: A randomized, longitudinal study. AIDS 12(18):2473–2480. Stanton, D. 2009. Program guidance and updates: Report on TAB, SOPA. Oral Presentation, The United States President’s Emergency Plan for AIDS Relief Annual Meeting, United States Government Days Meeting, Windhoek, Namibia, June8. Stover, J., B. Fidzani, B. C. Molomo, T. Moeti, and G. Musuka. 2008. Estimated HIV trends and program effects in Botswana. PLoS ONE 3(11):e3729. UNAIDS (United Nations Joint Programme on HIV/AIDS). 2004. “Three ones” key principles. Conference paper 1, Washington consultation of April 4, 2004. Geneva, Switzerland: UNAIDS. UNAIDS. 2006. 2006 report on the global AIDS epidemic. Geneva, Switzerland: UNAIDS. UNAIDS. 2008. Report on the global AIDS epidemic 2008. Geneva, Switzerland: UNAIDS. UNAIDS. 2009a. Operational plan for the UNAIDS action framework: Addressing women, girls, gender equality and HIV. Geneva, Switzerland: UNAIDS. UNAIDS. 2009b. Spectrum 2009: Estimates and projections of national HIV/AIDS epidemics. Presentation. http://data.unaids.org/pub/Presentation/2009/20090414_spectrum_2009_en.pdf (accessed June 22, 2010). UNAIDS. 2010a. Gender. http://www.unaids.org/en/PolicyAndPractice/Gender/default.asp (accessed April 27, 2010). UNAIDS. 2010b. Key populations. http://www.unaids.org/en/PolicyAndPractice/KeyPopulations/default.asp (accessed April 9, 2010). UNAIDS, UNICEF, and USAID (United Nations Joint Programme on HIV/AIDS, United Nations Children’s Fund, and United States Agency for International Development). 2002. Children on the brink 2002: A joint report on orphan estimates and program strategies. Washington, DC: UNAIDS/UNICEF/USAID. UNAIDS, UNICEF, and USAID. 2004. Children on the brink 2004: A joint report on new orphan estimates and a framework for action. Washington, DC: UNAIDS/UNICEF/USAID. UNAIDS and WHO (United Nations Joint Programme on HIV/AIDS and World Health Organization). 2009. AIDS epidemic update: December 2009. Geneva, Switzerland: UNAIDS. UNAIDS MERG (United Nations Joint Programme on HIV/AIDS Monitoring & Evaluation Reference Group). 2010. Guidance on developing terms of reference for HIV prevention evaluation. Geneva, Switzerland: UNAIDS. UNAIDS Reference Group on Estimates Modelling and Projections. 2002. Improved methods and assumptions for estimation of the HIV/AIDS epidemic and its impact: Recommendations of the UNAIDS Reference Group on Estimates, Modelling and Projections. AIDS 16(9):W1–W14. UNAIDS Reference Group on Estimates Modelling and Projections. 2007. Estimation of orphanhood due to HIV/AIDS and non-AIDS causes and the impact of intervention programmes. Report of a meeting of the UNAIDS Reference Group on Estimates, Modelling, and Projections, Baltimore, July 12. UNGASS (United Nations General Assembly Special Session). 2001. Declaration of commitment on HIV/AIDS. New York: United Nations.

OCR for page 133
141 REFERENCES UNICEF (United Nations Children’s Fund). 2004. The framework for the protection, care and support of orphans and vulnerable children living in a world with HIV and AIDS. New York: UNICEF. UNICEF. 2007. Enhanced protection for children affected by AIDS. A companion paper to the framework for the protection, care and support of orphans and vulnerable children living in a world with HIV and AIDS. New York: UNICEF. UNICEF. 2009. Children and AIDS: Fourth stocktaking report, 2009. New York: UNICEF, United Nations Joint Programme on HIV/AIDS, World Health Organization, and United Nations Population Fund. UNITAID and CHAI (UNITAID and Clinton Health Access Initiative). 2010. Agreement for the procurement and supply of second-line ARV drugs for 2010. Geneva, Switzerland: UNITAID. UNITAID. 2010. UNITAID: Mission. http://www.unitaid.eu/en/UNITAID-Mission.html (accessed April 11, 2010). United Nations. 1990. Convention on the Rights of the Child. New York: United Nations. United Nation. 2003. Monterrey Consensus on Financing for Development. The final text of agreements and commitments adopted at the International Conference on Financing for Development, Monterrey, Mexico, 18–22 March 2002. New York: United Nations. UNIFEM (United Nations Development Fund for Women). 2006. Transforming the national AIDS response: Mainstreaming gender equality and women’s human rights into the “Three Ones”. New York: UNIFEM. United Nations General Assembly. 2006. Political declaration on HIV/AIDS. New York: United Nations. United Nations Treaty Collection. 2010. Convention on the Rights of the Child (status as of 14-04-2010). http://treaties.un.org/Pages/ViewDetails.aspx?src=TREATY&mtdsg_no=IV- 11&chapter=4&lang=en (accessed April 16, 2010). USAID (United States Agency for International Development). 2000. USAID/India: Life initiative leadership and investment in fighting an epidemic. http://www.usaid.gov/press/releases/2000/fs20000079.htm (accessed May 6, 2010). USAID. 2009a. Food for peace. http://www.usaid.gov/our_work/humanitarian_assistance/ffp/history.html (accessed May 28, 2010). USAID. 2009b. USAID’s HIV/AIDS annual budget. http://www.usaid.gov/our_work/global_health/aids/Funding/index.html (accessed May 6, 2010). USAID and DoS. 2009 (United States Agency for International Development and U.S. Department of State). Addressing water challenges in the developing world: A framework for action. Washington, DC: Bureau of Economic Growth, Agriculture, and Trade, U.S. Agency for International Development and Bureau of Oceans, Environment, and Science, U.S. Department of State. U.S. Census Bureau. 2009. International data base: Population estimates and projections methodology. Washington, DC: U.S. Census Bureau. Violari, A., M. F. Cotton, D. M. Gibb, A. G. Babiker, J. Steyn, S. A. Madhi, P. Jean-Philippe, and J. A. McIntyre. 2008. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 359(21):2233–2244. von Linstow, M. L., V. Rosenfeldt, A. M. Lebech, M. Storgaard, T. Hornstrup, T. L. Katzenstein, G. Pedersen, T. Herlin, N. H. Valerius, and N. Weis. 2010. Prevention of mother-to-child transmission of HIV in Denmark, 1994–2008. HIV Med (Epub ahead of print). WHO (World Health Organization). 1999. Programming for adolescent health and development. Report of a WHO/UNFPA/UNICEF study group. Geneva, Switzerland: WHO. WHO. 2006a. Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults: Recommendations for a public health approach. Geneva, Switzerland: WHO. WHO. 2006b. Patient monitoring guidelines for HIV care and antiretroviral therapy (ART). Geneva, Switzerland: WHO.

OCR for page 133
142 STRATEGIC APPROACH TO THE EVALUATION OF U.S. GLOBAL HIV/AIDS PROGRAMS WHO. 2006c. Preventing HIV/AIDS in young people. A systematic review of the evidence from developing countries. Geneva, Switzerland: WHO. WHO. 2007a. Everybody’s business: Strengthening health systems to improve health outcomes. WHO’s framework for action. Geneva, Switzerland: WHO. WHO. 2007b. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva, Switzerland: WHO. WHO. 2008. Essential prevention and care interventions for adults and adolescents living with HIV in resource-limited settings. Geneva, Switzerland: WHO. WHO. 2009a. Rapid advice: Antiretroviral therapy for HIV infection in adults and adolescents. Geneva, Switzerland: WHO. WHO. 2009b. Rapid advice: Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Geneva, Switzerland: WHO. WHO. 2009c. Rapid advice: WHO principles and recommendations on infant feeding in the context of HIV. Geneva, Switzerland: WHO. WHO. 2009d. Women and health : Today’s evidence tomorrow’s agenda. Geneva, Switzerland: WHO. WHO. 2010. Antiretroviral therapy for HIV infection in infants and children: Towards universal access. Executive summary of recommendations. Preliminary version for program planning. Geneva, Switzerland: WHO. WHO, UNAIDS, and UNICEF (World Health Organization, United Nations Joint Programme on HIV/AIDS, and United Nations Children’s Fund). 2009. Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector. Progress report 2009. Geneva, Switzerland: WHO. WHO, UNFPA, and UNICEF (World Health Organization, United Nations Population Fund, and United Nations Children’s Fund). 1997. Action for adolescent health: Towards a common agenda. Recommendations from a joint study group. Geneva, Switzerland: WHO. Wood, E., T. Kerr, B. D. Marshall, K. Li, R. Zhang, R. S. Hogg, P. R. Harrigan, and J. S. Montaner. 2009. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: Prospective cohort study. BMJ 338:b1649. World Bank. 2007. The Africa Multi-country AIDS Program, 2000–2006: Results of the World Bank’s response to a development crisis, edited by M. Görgens-Albino, N. Mohammad, D. Blankhart, and O. Odutolu. Washington, DC: The World Bank. World Bank. 2010. Projects & Operations. http://web.worldbank.org/WBSITE/EXTERNAL/PROJECTS/0,,menuPK:115635~pagePK:6402 0917~piPK:64021009~theSitePK:40941,00.html (accessed June 23, 2010). Zachariah, R., A. D. Harries, M. Philips, L. Arnould, K. Sabapathy, D. P. O’Brien, C. Ferreyra, and S. Balkan. 2010. Antiretroviral therapy for HIV prevention: Many concerns and challenges, but are there ways forward in sub-Saharan Africa? Trans R Soc Trop Med Hyg 104(6): 387–391.